IL‐4 down‐regulates the responsiveness of human intraepithelial lymphocytes

IL‐4 is an important regulator of intestinal inflammation, yet little is known regarding its action on intestinal lymphocytes. Intestinal lymphocytes were isolated from jejunal mucosa of patients undergoing gastric bypass operations for morbid obesity. The impact of IL‐4 was measured by its effects on proliferation using 3H‐thymidine incorporation, IL‐2 production using the CTLL assay, and IL‐2 receptor generation using immunofluorescence. The production of IL‐4 was measured by ELISA. IL‐4 significantly inhibited the proliferation of intraepithelial lymphocytes (IEL) to a variety of stimuli as well as the development of lymphokine‐activated killer (LAK) cells. In contrast, it had no effect on the proliferation of CD8+ T cells from peripheral blood. The inhibitory effect of IL‐4 on IEL did not occur during activation, since IL‐2 production and receptor expression were not altered. Rather, it occurred during cell cycling, since over 50% inhibition resulted whether IL‐4 was added at the initiation of an IL‐2‐stimulated culture or after 24 or 48 h incubation. IL‐4 was secreted by activated lamina propria lymphocytes (LPL) but not by IEL. IL‐4,produced by activated LPL, may enter the epithelial compartment and down‐regulate responsiveness of IEL.

[1]  D. Longo,et al.  IL-4 inhibits IL-2-induced tumoricidal activity and secretory functions of human monocytes. Modulation of IL-2 binding and IL-2 receptor beta gamma chain expression. , 1995, Journal of immunology.

[2]  U. Panzer,et al.  Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease. , 1995, Gastroenterology.

[3]  M. Kopf,et al.  Impaired mucosal immune responses in interleukin 4-targeted mice. , 1995, The Journal of experimental medicine.

[4]  E. Ebert,et al.  Intestinal mucosal lymphocytes have H1 receptors: H1 antagonists reduce their proliferation and cytotoxicity. , 1994, Cellular immunology.

[5]  R. Coffman,et al.  Interleukin‐4 and interleukin‐10 synergize to inhibit cell‐mediated immunity in vivo , 1993, European journal of immunology.

[6]  J. Banchereau,et al.  IL-4 inhibits growth factor-stimulated rheumatoid synoviocyte proliferation by blocking the early phases of the cell cycle. , 1993, Journal of immunology.

[7]  J. Banchereau,et al.  Interleukin 4 inhibits in vitro proliferation of leukemic and normal human B cell precursors. , 1992, The Journal of clinical investigation.

[8]  O. Majdic,et al.  Regulation of interleukin‐4 production in human mononuclear cells , 1992, European journal of immunology.

[9]  A. Sher,et al.  IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. , 1992, Journal of immunology.

[10]  C. Dinarello,et al.  Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[11]  W. Paul,et al.  CD8+ T cells can be primed in vitro to produce IL-4. , 1992, Journal of immunology.

[12]  M. Poot,et al.  Interleukin 4 drives phytohemagglutinin-activated T cells through several cell cycles: no synergism between interleukin 2 and interleukin 4. , 1991, Cytokine.

[13]  E. Ebert,et al.  Selective immunosuppressive action of a factor produced by colon cancer cells. , 1990, Cancer research.

[14]  M. Thornhill,et al.  IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-gamma. , 1990, Journal of immunology.

[15]  J. Yagüe,et al.  Inhibitory effect of IL-4 on the sepharose-CD3-induced proliferation of the CD4CD45RO human T cell subset. , 1990, International immunology.

[16]  F. Aronson,et al.  IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T cells. , 1990, Journal of immunology.

[17]  W. Kwan,et al.  T cells in inductive and effector compartments of the intestinal mucosal immune system of nonhuman primates differ in lymphokine mRNA expression, lymphokine utilization, and regulatory function. , 1990, Journal of immunology.

[18]  E. Ebert.  Proliferative responses of human intraepithelial lymphocytes to various T-cell stimuli. , 1989, Gastroenterology.

[19]  S. Rosenberg,et al.  IL-4 regulates IL-2 induction of lymphokine-activated killer activity from human lymphocytes. , 1989, Journal of immunology.

[20]  L. Davis,et al.  Promotion of human T lymphocyte proliferation by IL-4. , 1989, Journal of immunology.

[21]  G. Gallagher,et al.  Interleukin-3 and interleukin-4 each strongly inhibit the induction and function of human LAK cells. , 1988, Clinical and experimental immunology.

[22]  R. Rees,et al.  Human recombinant IL-4 suppresses the induction of human IL-2 induced lymphokine activated killer (LAK) activity. , 1988, Clinical and experimental immunology.

[23]  M. Brown,et al.  IL-4/B cell stimulatory factor 1 stimulates T cell growth by an IL-2-independent mechanism. , 1988, Journal of immunology.

[24]  K. Heeg,et al.  Interleukin 4 (BSF‐1) induces growth in resting murine CD8 T cells triggered via cross‐linking of T3 cell surface structures , 1988, European journal of immunology.

[25]  K. Arai,et al.  B cell growth-promoting activity of recombinant human interleukin 4. , 1987, Journal of immunology.

[26]  E. Shevach,et al.  B cell stimulatory factor 1 (interleukin 4) is a potent costimulant for normal resting T lymphocytes , 1987, The Journal of experimental medicine.

[27]  R. Fernandez-Botran,et al.  B cell-stimulatory factor 1 (BSF-1) promotes growth of helper T cell lines , 1986, The Journal of experimental medicine.